VERU INC. Deferred Costs, Noncurrent
VERU INC. (VERU) had Deferred Costs, Noncurrent of $424.92 thousand as of 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2018-05-11
- 2018-03-31: Deferred Costs, Noncurrent $424.92K.
- 2017-12-31: Deferred Costs, Noncurrent $423.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2018-03-31 | $424.92K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $423.00K 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |